ADIPOQ and systemic sclerosis: A recent meta-analysis, despite the significant heterogeneity observed among the eligible studies, showed that adiponectin levels are significantly lower in SSc patients than normal controls, while on the contrary no significant differences in serum leptin levels were observed (28, 32, 35).